Anmelden/Registrieren
Erscheinungsjahr:
 
Zurück zur geteilten Ansicht
Howard I. Scher

Veröffentlichungen von Howard I. Scher zu Scher, Howard ->
weitere Veröffentlichungen von Howard I. Scher:
Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer (1984)
Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephroma (1985)
Phase II trial of 10 deaza-aminopterin in patients with bladder cancer (1986)
Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer (1993)
A peptidomimetic inhibitor of ras functionality markedly suppresses growth of human prostate tumor xenografts in mice. Prospects for long-term clinical utility (2000)
Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable disease (1986)
Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency (1990)
Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression (1998)
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis (2005)
Veröffentlichungen zu Scher, Howard
Zurück zur geteilten Ansicht
Verfasser Titel Jahr absteigend sortierenaufsteigend sortieren
zeige Details
1
Amler, Lukas, Agus, David, ... Functional dissection of transcriptional profiles in androgen-dependent and -independent prostate cancer
in: Nature genetics . - New York, NY : Nature America, ISSN 1546-1718, Vol. 27 Suppl 1, No. 4s (2001), p. 39-39
Zugang: zum Volltext
ähnliche Vorschläge
2001
zeige Details
2
Scher, Howard I., Kelsen, David, ... Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 12 (2. 1984), p. 101-103
Zugang: zum Volltext
ähnliche Vorschläge
1984
zeige Details
3
Scher, Howard I., Yagoda, Alan, ... Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephroma
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 14 (1. 1985), p. 79-80
Zugang: zum Volltext
ähnliche Vorschläge
1985
zeige Details
4
Ahmed, Tauseef, Yagoda, Alan, ... Phase II trial of 10 deaza-aminopterin in patients with bladder cancer
in: Investigational new drugs , ISSN 1573-0646, Vol. 4 (2. 1986), p. 171-174
Zugang: zum Volltext
ähnliche Vorschläge
1986
zeige Details
5
Motzer, Robert, Scher, Howard, ... Phase II trial of Didemnin B in patients with advanced renal cell carcinoma
in: Investigational new drugs , ISSN 1573-0646, Vol. 8 (4. 1990), p. 391-392
Zugang: zum Volltext
ähnliche Vorschläge
1990
zeige Details
6
Baselga, Jose, Kris, Mark G., ... Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer
in: Investigational new drugs , ISSN 1573-0646, Vol. 11 (1. 1993), p. 85-86
Zugang: zum Volltext
ähnliche Vorschläge
1993
zeige Details
7
Sirotnak, F. M., Sepp-Lorenzino, Laura, ... A peptidomimetic inhibitor of ras functionality markedly suppresses growth of human prostate tumor xenografts in mice. Prospects for long-term clinical utility
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 46 (1. 2000), p. 79-83
Zugang: zum Volltext
ähnliche Vorschläge
2000
zeige Details
8
Scher, Howard I., Sternberg, Cora, ... Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable disease
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 18 (1. 1986), p. 24-26
Zugang: zum Volltext
ähnliche Vorschläge
1986
zeige Details
9
Pfister, David G., Bajorin, Dean, ... A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer
in: Investigational new drugs , ISSN 1573-0646, Vol. 11 (1. 1993), p. 53-56
Zugang: zum Volltext
ähnliche Vorschläge
1993
zeige Details
10
Motzer, Robert J., Niedzwiecki, Donna, ... Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency
in: Cancer chemotherapy and pharmacology , ISSN 1432-0843, Vol. 27 (3. 1990), p. 234-238
Zugang: zum Volltext
ähnliche Vorschläge
1990
zeige Details
11
Papandreou, Christos N., Usmani, Badar, ... Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression
in: Nature medicine . - New York, NY : Nature America Inc., ISSN 1546-170X, Vol. 4, No. 1 (1998), p. 50-57
Zugang: zum Volltext
ähnliche Vorschläge
1998
zeige Details
12
Amler, Lukas, Agus, David, ... Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model, CWR22-R
in: Nature genetics . - New York, NY : Nature America, ISSN 1546-1718, Vol. 27 Suppl 1, No. 4s (2001), p. 39-39
Zugang: zum Volltext
ähnliche Vorschläge
2001
zeige Details
13
Chen, Zhenbang, Trotman, Lloyd C., ... Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
in: Nature . - London [u.a.] : Nature Publising Group, ISSN 1476-4687, Vol. 436, No. 7051 (2005), p. 725-730
Zugang: zum Volltext
ähnliche Vorschläge
2005